Lympho-geographical concepts in vaccine delivery.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Controlled Release

• Publication date

  2010-11-20

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.jconrel.2010.05.019PMID 20562028
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in the design and delivery of peptide subunit vaccines with a focus on Toll-like receptor agonists

  2010cited by this paper
• Immunology of TLR-independent vaccine adjuvants.

  2009cited by this paper
• Adjuvants for pandemic influenza vaccines.

  2009cited by this paper
• Materials engineering for immunomodulation

  2009cited by this paper
• Influenza vaccines

  2009cited by this paper
• Intralymphatic immunotherapy

  2009cited by this paper
• Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles.

  2009cited by this paper
• Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system.

  2009cited by this paper
• Intralymphatic Injections as a New Administration Route for Allergen-Specific Immunotherapy

  2009cited by this paper
• Virosomal hepatitis a vaccine: comparing intradermal and subcutaneous with intramuscular administration.

  2009cited by this paper
• Strategies for optimizing targeting and delivery of mucosal HIV vaccines

  2009cited by this paper
• Novel adjuvants for B cell immune responses

  2009cited by this paper
• Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators

  2009cited by this paper
• Virus-like particle vaccines and adjuvants: the HPV paradigm

  2009cited by this paper
• Virus-like Particle (VLP) Lymphatic Trafficking and Immune Response Generation After Immunization by Different Routes

  2009cited by this paper
• Adjuvants for malaria vaccines

  2009cited by this paper
• Antigen kinetics determines immune reactivity

  2008cited by this paper
• Cutting Edge: Inflammasome Activation by Alum and Alum’s Adjuvant Effect Are Mediated by NLRP31

  2008cited by this paper
• Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial

  2008cited by this paper
• A Protective Allergy Vaccine Based on CpG- and Protamine-Containing PLGA Microparticles

  2007cited by this paper
• Bacterial ghosts as adjuvant particles

  2007cited by this paper
• Particulate systems as adjuvants and carriers for peptide and protein antigens.

  2006cited by this paper
• Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling

  2006cited by this paper
• Dendritic-cell trafficking to lymph nodes through lymphatic vessels

  2005cited by this paper
• Direct intralymphatic injection of peptide vaccines enhances immunogenicity

  2005cited by this paper
• Immunity in response to particulate antigen-delivery systems.

  2005cited by this paper
• The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node.

  2005cited by this paper
• Migratory Langerhans cells in mouse lymph nodes in steady state and inflammation.

  2005cited by this paper
• Visualizing the first 50 hr of the primary immune response to a soluble antigen.

  2004cited by this paper
• Dose sparing with intradermal injection of influenza vaccine.

  2004cited by this paper
• Regulation of Dendritic Cell Migration to the Draining Lymph Node

  2003cited by this paper
• The Strategy of T Cell Antigen-presenting Cell Encounter in Antigen-draining Lymph Nodes Revealed by Imaging of Initial T Cell Activation

  2003cited by this paper
• Antigen presentation to naive CD4 T cells in the lymph node

  2003cited by this paper
• Homing and cellular traffic in lymph nodes

  2003cited by this paper
• Travellers in many guises: The origins and destinations of dendritic cells

  2002cited by this paper
• Hepatitis A vaccination by intracutaneous low dose administration: a less expensive alternative.

  1996cited by this paper
• Approaching the asymptote? Evolution and revolution in immunology.

  1989cited by this paper
• Experimental studies on the pathogenesis of contact eczema in the guinea-pig.

  1957cited by this paper

• Amplifying the Immune Activity of Metal Ions through Metal-Phenolic Complexation.

  2025cites this paper
• State-of-the-Art Review on Liposomes as Versatile Cancer Vaccine Delivery Systems

  2025cites this paper
• Shaping Antitumor Immunity with Peptide Vaccines: Implications of Immune Modulation at the Vaccine Site

  2025cites this paper
• Zwitterionic peptide pendant as a homing agent to achieve lymphatic targeting antigen-specific immunotherapy of allergenic protein

  2024cites this paper
• A MnAl double adjuvant nanovaccine to induce strong humoral and cellular immune responses.

  2023cites this paper
• Engineered Ferritin Nanoparticle Vaccines Enable Rapid Screening of Antibody Functionalization to Boost Immune Responses

  2023cites this paper
• Critical Elements of an Mpox Vaccination Model at the Largest Public Health Hospital System in the United States

  2023cites this paper
• Non-canonical inflammasome activation mediates the adjuvanticity of nanoparticles

  2023cites this paper
• Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid

  2023cites this paper
• Lymph Node–Targeted Vaccine Boosting of TCR T-cell Therapy Enhances Antitumor Function and Eradicates Solid Tumors

  2022cites this paper
• Adjuvant Effects of Pseudomonas aeruginosa Flagellin on the Immunological Patterns of the HIV-1 Vaccine Candidate: Vaccine Formulations Versus Different Routes of Immunization

  2022cites this paper
• Does an Intradermal Vaccination for Monkeypox Make Sense?

  2022cites this paper
• Polymeric particle-based therapies for acute inflammatory diseases

  2022cites this paper
• Advances in the polymeric delivery of nucleic acid vaccines

  2022cites this paper
• Glycosylation of OVA antigen-loaded PLGA nanoparticles enhances DC-targeting for cancer vaccination.

  2022cites this paper
• Engineering a self-navigated MnARK nanovaccine for inducing potent protective immunity against novel coronavirus

  2021cites this paper
• Emerging theranostic gold nanostructures to combat cancer: Novel probes for Combinatorial Immunotherapy and Photothermal Therapy.

  2020cites this paper
• Nanomedicine for improvement of dendritic cell-based cancer immunotherapy.

  2020cites this paper
• Intradermal and transdermal drug delivery using microneedles - Fabrication, performance evaluation and application to lymphatic delivery.

  2019cites this paper
• Real‐Time Imaging of Vaccine Biodistribution Using Zwitterionic NIR Nanoparticles

  2019cites this paper
• Delivery technologies for cancer immunotherapy

  2019cites this paper
• Self-assembled CpG oligodeoxynucleotides conjugated hollow gold nanospheres to enhance cancer-associated immunostimulation.

  2019cites this paper
• Personalized Peptide-based vaccination for treatment of colorectal cancer: rational and progress.

  2019cites this paper
• Nanomedicine Approaches Against Parasitic Worm Infections

  2018cites this paper
• Current challenges for cancer vaccine adjuvant development

  2018cites this paper
• Intraperitoneal administration of aluminium‐based adjuvants produces severe transient systemic adverse events in mice

  2018cites this paper
• Development of a Novel, Peptide-based Vaccine for Lyme Disease

  2017cites this paper
• Targeting CpG Adjuvant to Lymph Node via Dextran Conjugate Enhances Antitumor Immunotherapy.

  2017cites this paper
• Calcium phosphate nanoparticles as a new generation vaccine adjuvant

  2017cites this paper
• Intralymphatic Administration of Adipose Mesenchymal Stem Cells Reduces the Severity of Collagen-Induced Experimental Arthritis

  2017cites this paper
• Biodistribution and Efficacy of Human Adipose-Derived Mesenchymal Stem Cells Following Intranodal Administration in Experimental Colitis

  2017cites this paper
• Novel strategies for the treatment of grass pollen-induced allergic rhinitis

  2016cites this paper
• Drug Delivery to the Lymphatic System

  2016cites this paper
• Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy.

  2016cites this paper
• Toll-like receptors targeting technology for the treatment of lymphoma

  2016cites this paper
• Novel Delivery Routes for Allergy Immunotherapy: Intralymphatic, Epicutaneous, and Intradermal.

  2016cites this paper
• Adjuvants for peptide-based cancer vaccines

  2016cites this paper
• Aliphatic Polyesters: Particulate Vaccine Delivery

  2015cites this paper
• Efficacy of Autologous Serum Therapy in Patients with Recalcitrant Chronic Urticaria and Positive Autologous Serum Skin Test

  2015cites this paper
• Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization

  2015cites this paper
• Parenteral Vaccine Administration: Tried and True

  2015cites this paper
• Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: Association between injection quality and immunogenicity.

  2015cites this paper
• Rapid and Persistent Delivery of Antigen by Lymph Node Targeting PRINT Nanoparticle Vaccine Carrier To Promote Humoral Immunity.

  2015cites this paper
• Choice and Design of Adjuvants for Parenteral and Mucosal Vaccines

  2015cites this paper
• Intralymphatic immunotherapy and vaccination in mice.

  2014cites this paper
• Hitchhiker's guide to the lymph node

  2014cites this paper
• Development of a melanoma therapeutic vaccine candidate by the coencapsulation of melanoma antigen peptides and toll-like receptor ligands as adjuvants into polymeric nanoparticles

  2014cites this paper
• Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant.

  2014cites this paper
• Nanotechnology for the delivery of vaccines

  2014cites this paper
• Combatting infectious diseases; nanotechnology as a platform for rational vaccine design.

  2014cites this paper
• Immunization with a Borrelia burgdorferi BB0172-Derived Peptide Protects Mice against Lyme Disease

  2014cites this paper
• Structure-based programming of lymph-node targeting in molecular vaccines

  2014cites this paper
• Autohemotherapy in Chronic Urticaria: What Could Be the Autoreactive Factors and Curative Mechanisms?

  2014cites this paper
• Immunomodulation against microbial pathogens through dendritic cells

  2013cites this paper
• New Directions in Immunotherapy

  2013cites this paper
• Virosomes-Hybrid Drug Delivery Systems

  2013cites this paper
• Designing Liposomes as Vaccine Adjuvants

  2013cites this paper
• New routes for allergen immunotherapy

  2012cites this paper
• Cationic liposomal vaccine adjuvants in animal challenge models: overview and current clinical status

  2012cites this paper
• License to kill: Formulation requirements for optimal priming of CD8(+) CTL responses with particulate vaccine delivery systems.

  2012cites this paper
• Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines.

  2011cites this paper
• In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles

  2011cites this paper
• Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems.

  2011cites this paper
• Differential Effects of Viral Vectors on Migratory Afferent Lymph Dendritic Cells In Vitro Predict Enhanced Immunogenicity In Vivo

  2011cites this paper
• Small is beautiful: N-trimethyl chitosan-ovalbumin conjugates for microneedle-based transcutaneous immunisation.

  2011cites this paper
• Chapter 7

  2010cites this paper
• Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.

  2010cites this paper
• Year : 2014 Intralymphatic immunotherapy and vaccination in mice

  year unknowncites this paper